These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23933573)

  • 1. Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid.
    Penno CA; Morgan SA; Vuorinen A; Schuster D; Lavery GG; Odermatt A
    J Lipid Res; 2013 Oct; 54(10):2874-83. PubMed ID: 23933573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
    Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
    Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonyl reduction of triadimefon by human and rodent 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Da Cunha T; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Biochem Pharmacol; 2013 May; 85(9):1370-8. PubMed ID: 23419873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Drug Metab Dispos; 2013 Sep; 41(9):1671-8. PubMed ID: 23804523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bile acids on rat hepatic microsomal type I 11beta-hydroxysteroid dehydrogenase.
    Maeda Y; Naganuma S; Niina I; Shinohara A; Koshimoto C; Kondo K; Chijiiwa K
    Steroids; 2010 Feb; 75(2):164-8. PubMed ID: 19948178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse.
    Weingartner M; Stücheli S; Kratschmar DV; Birk J; Klusonova P; Chapman KE; Lavery GG; Odermatt A
    Br J Pharmacol; 2021 Aug; 178(16):3309-3326. PubMed ID: 33450045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of human serum albumin on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase.
    Maeda Y; Funagayama M; Shinohara A; Koshimoto C; Furusawa H; Nakahara H; Yamaguchi Y; Saitoh T; Yamamoto T; Komaki K
    J Physiol Biochem; 2014 Sep; 70(3):849-55. PubMed ID: 25108556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.
    Morris DJ; Souness GW; Latif SA; Hardy MP; Brem AS
    Metabolism; 2004 Jun; 53(6):811-6. PubMed ID: 15164334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guinea pig 11beta-hydroxysteroid dehydrogenase type 1: primary structure and catalytic properties.
    Pu X; Yang K
    Steroids; 2000 Mar; 65(3):148-56. PubMed ID: 10699594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational Modeling.
    Liu H; Li L; Zhang C; Li H; Liu J; Tang C; Zhang Y; Wu D; Chu Y; Wu Y; Yuan X
    Pharmacology; 2018; 102(3-4):169-179. PubMed ID: 30099452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV-filter benzophenones suppress human, pig, rat, and mouse 11β-hydroxysteroid dehydrogenase 1: Structure-activity relationship and in silico docking analysis.
    Hao T; Zhao X; Ji Z; Xia M; Lu H; Sang J; Wang S; Li L; Ge RS; Zhu Q
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jul; 281():109900. PubMed ID: 38518984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-Hydroxysteroid dehydrogenase-1 is involved in bile acid homeostasis by modulating fatty acid transport protein-5 in the liver of mice.
    Penno CA; Morgan SA; Rose AJ; Herzig S; Lavery GG; Odermatt A
    Mol Metab; 2014 Aug; 3(5):554-64. PubMed ID: 25061560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition.
    Gómez C; Alimajstorovic Z; Othonos N; Winter DV; White S; Lavery GG; Tomlinson JW; Sinclair AJ; Odermatt A
    Br J Pharmacol; 2024 Mar; 181(5):698-711. PubMed ID: 37740611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
    Hong SP; Han D; Chang KH; Ahn SK
    Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.